Related Experiment Video
Updated: May 9, 2026
A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood
Published on: February 8, 2016
Integration of lyoplate based flow cytometry and computational analysis for standardized immunological biomarker
Federica Villanova1, Paola Di Meglio, Margaret Inokuma
1St John's Institute of Dermatology, King's College London, London, United Kingdom.
Insights
A new lyoplate-based flow cytometry platform (LFP) offers higher sensitivity for discovering immune biomarkers compared to conventional methods. This advancement aids in monitoring immune-mediated inflammatory diseases and response to therapy.
Area of Science:
- Immunology
- Biomarker Discovery
- Flow Cytometry
Background:
- Monitoring disease prognosis and therapy response in immune-mediated inflammatory diseases requires novel immune biomarkers.
- Current methods for biomarker discovery face limitations in sensitivity and throughput.
Purpose of the Study:
- To establish and evaluate a novel framework for immunological biomarker discovery using a lyoplate-based flow cytometry platform (LFP).
- To compare the performance of LFP against a conventional flow cytometry platform (CFP).
Main Methods:
- Comparison of LFP and CFP for detecting cytokines (IFN-γ, IL-10) and activation markers (Foxp3, CD25).
- Utilized advanced computational data analysis, including automated immunophenotyping.
- Assessed sample processing throughput and assay variability.
Main Results:
- LFP demonstrated higher sensitivity than CFP, with increased detection of key immune markers.
- Lyophilized antibodies in LFP resulted in higher fluorescent intensity compared to liquid antibodies.
- Automated analysis identified novel immunophenotypes missed by manual analysis.
- LFP enabled medium-throughput sample processing with comparable assay variability.
Conclusions:
- LFP represents a new, standardized, and rapid platform for immunological biomarker discovery.
- This platform has wide applications in the study and management of immune-mediated diseases.
- LFP enhances the detection capabilities for critical immune response indicators.
Abstract:
Discovery of novel immune biomarkers for monitoring of disease prognosis and response to therapy in immune-mediated inflammatory diseases is an important unmet clinical need. Here, we establish a novel framework for immunological biomarker discovery, comparing a conventional (liquid) flow cytometry platform (CFP) and a unique lyoplate-based flow cytometry platform (LFP) in combination with advanced computational data analysis. We demonstrate that LFP had higher sensitivity compared to CFP, with increased detection of cytokines (IFN-γ and IL-10) and activation markers (Foxp3 and CD25). Fluorescent intensity of cells stained with lyophilized antibodies was increased compared to cells stained with liquid antibodies. LFP, using a plate loader, allowed medium-throughput processing of samples with comparable intra- and inter-assay variability between platforms. Automated computational analysis identified novel immunophenotypes that were not detected with manual analysis. Our results establish a new flow cytometry platform for standardized and rapid immunological biomarker discovery with wide application to immune-mediated diseases.
